NOS3 rs1699614: Exercise Blood Flow and Capillarization
The rs1699614 variant is a single-nucleotide polymorphism located in the NOS3 gene, which encodes endothelial nitric oxide synthase. This enzyme produces nitric oxide, a key signaling molecule that regulates vasodilation and local blood flow in human tissues. Research associates this variant with subtle differences in vascular hemodynamics, muscle capillarization, and physiological responsiveness to aerobic exercise training.
What each genotype means
Unknown fitness association
There is no established scientific evidence linking this genotype to NOS3 gene function, blood flow, or aerobic exercise response. Research primarily associates this variant with other regions of the genome; therefore, this result does not provide actionable insight into your fitness or cardiovascular physiology.
Frequency data for this specific genotype varies significantly by ancestry and is documented in large-scale databases like gnomAD.
Unknown fitness association
There is no established scientific evidence linking this genotype to NOS3 gene function, blood flow, or aerobic exercise response. Research primarily associates this variant with other regions of the genome; therefore, this result does not provide actionable insight into your fitness or cardiovascular physiology.
Frequency data for this specific genotype varies significantly by ancestry and is documented in large-scale databases like gnomAD.
Unknown fitness association
There is no established scientific evidence linking this genotype to NOS3 gene function, blood flow, or aerobic exercise response. Research primarily associates this variant with other regions of the genome; therefore, this result does not provide actionable insight into your fitness or cardiovascular physiology.
Frequency data for this specific genotype varies significantly by ancestry and is documented in large-scale databases like gnomAD.
Genetic Architecture and Genomic Location
The single-nucleotide polymorphism rs1699614 resides within the NOS3 gene on chromosome 7q36. NOS3 spans 26 exons and encodes the endothelial isoform of nitric oxide synthase, commonly referred to as eNOS. Variants in this locus include both coding missense mutations and noncoding regulatory single-nucleotide polymorphisms located in flanking or intronic regions. While rs1699614 does not cause an amino acid substitution, noncoding variants across the NOS3 architecture can influence transcription factor binding affinity, primary transcript stability, or alternative splicing mechanisms. Understanding the position of rs1699614 within this regulatory framework allows researchers to examine how subtle shifts in genomic sequence might alter baseline enzymatic production across diverse human vascular tissues.
Biological Role of the NOS3 Gene Product
Endothelial nitric oxide synthase catalyzes the synthesis of nitric oxide (NO) and L-citrulline from L-arginine and molecular oxygen, utilizing crucial cofactors such as tetrahydrobiopterin (BH4) and NADPH. In the cardiovascular system, nitric oxide readily diffuses into adjacent vascular smooth muscle cells, triggering soluble guanylyl cyclase to elevate cyclic guanosine monophosphate (cGMP) concentrations. This cascade stimulates smooth muscle relaxation, prompting vasodilation and optimizing perfusion pressure throughout peripheral vascular beds. Beyond acute regulation of vascular tone, endothelial-derived nitric oxide cooperates closely with vascular endothelial growth factor (VEGF) signaling pathways to orchestrate angiogenesis, a vital physiological process driving the growth and structural remodeling of capillary networks in response to tissue hypoxia and muscular exertion.
Fitness Associations and Current Evidence Strength
In exercise physiology, scientists have evaluated rs1699614 for its potential association with aerobic adaptations, specifically blood flow delivery and skeletal muscle capillarization following endurance protocols. When muscles contract during aerobic training, shear stress against vascular walls stimulates eNOS upregulation, boosting nitric oxide availability to foster capillary expansion and microvascular remodeling. While candidate-gene investigations have suggested that specific genotypes at rs1699614 may be linked to differing rates of vascular remodeling or hemodynamic adaptation, broader genome-wide association studies (GWAS) emphasize that cardiorespiratory fitness and endurance traits are broadly polygenic. Consequently, the scientific evidence supporting rs1699614 as an isolated performance predictor remains classified as limited, characterized by modest effect sizes and noticeable heterogeneity across experimental cohorts.
Population Distribution and Ancestral Patterns
Allele frequencies for rs1699614 demonstrate significant variability across global ancestral groups. Data from large-scale reference sets, including the Genome Aggregation Database (gnomAD), identify the global minor allele frequency (MAF) at approximately 0.31, confirming that both common alleles circulate widely throughout the human population. However, allele distribution is not uniform across all ancestries: frequencies differ substantially between European, African, East Asian, and admixed populations. Because background linkage disequilibrium structures vary across ancestral lineages, the statistical associations discovered in one cohort cannot automatically be generalized to individuals of different genealogical backgrounds, underscoring the importance of interpreting genetic fitness data within relevant ancestral frameworks.
Actionability and Practical Exercise Guidance
Knowledge of your rs1699614 genotype is informative for understanding personal genetic predispositions, but it is neither diagnostic nor deterministic of athletic capacity. Having a particular genotype does not guarantee superior endurance performance, nor does it preclude someone from achieving exceptional cardiorespiratory fitness. Lifestyle habits, structured aerobic exercise, progressive overload, sleep quality, and proper nutrition exert a profoundly larger influence on muscle capillarization and endothelial health than any solitary DNA variant. Individuals can foster endogenous nitric oxide production naturally through sustained cardiovascular training and a diet rich in polyphenols and dietary nitrates, regardless of their specific genetic makeup at this single locus.
How common is this variant?
According to gnomAD reference datasets, the global minor allele frequency (MAF) for rs1699614 is approximately 0.31, indicating that the alternative allele is common across global populations with observed variations in frequency across distinct ancestral backgrounds.
Frequently asked questions
Can my rs1699614 genotype predict my endurance sports performance?
No, this genetic variant cannot reliably predict your endurance potential or athletic success. Human exercise performance is highly polygenic, shaped by thousands of minor genetic variants acting in concert with physical training, nutrition, and environmental factors.
Does rs1699614 cause cardiovascular disease or hypertension?
No, rs1699614 is not classified by clinical databases as a direct or causal pathogenic mutation for heart disease or high blood pressure. While NOS3 variants modulate endothelial pathways, clinical cardiovascular outcomes are determined by broad polygenic factors and lifestyle choices.
Can taking nitric oxide supplements overcome a specific NOS3 genotype?
Dietary nitrates and supplements like L-citrulline provide metabolic substrates for nitric oxide generation, but their effects occur independently of modifying your underlying DNA sequence. A nutrient-dense diet containing leafy greens alongside regular physical exercise naturally supports healthy endothelial function across all genotypes.
Why is the evidence for rs1699614 described as limited?
The evidence is considered limited because most reported links come from smaller candidate-gene fitness studies rather than massive, replicated genome-wide association studies. In polygenic traits like muscle capillarization, isolated variants typically account for only a negligible fraction of physiological variation.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1699614?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in NOS3
Promoter variant (-786T>C) in the NOS3 gene associated with endothelial nitric oxide synthase expression and cardiovascular risk.
Also known as Glu298Asp (894G>T), this variant affects endothelial nitric oxide synthase cleavage and vascular tone, modulating exercise-induced vasodilation and aerobic performance.
An intronic endothelial nitric oxide synthase polymorphism that influences vascular tone, exercise-induced vasodilation, and aerobic endurance performance.
Commonly studied variant in the endothelial nitric oxide synthase gene, associated with cardiovascular traits.
Promoter-adjacent polymorphism affecting endothelial nitric oxide synthase transcription, modulating exercise-induced vasodilation and aerobic trainability.
The Glu298Asp variant in the NOS3 gene is associated with altered nitric oxide production and may influence susceptibility to cardiovascular conditions like hypertension and coronary artery disease.